Why Retatrutide Might Differ There are theoretical reasons to believe retatrutide's triple-agonist mechanism could produce a more favorable body composition outcome than GLP-1-only drugs: The glucagon hypothesis Glucagon receptor activation unique to retatrutide among advanced clinical candidates has several effects that could preferentially target fat over muscle: Promotes lipolysis the breakdown of stored fat for energy, potentially directing the body to draw more energy from fat stores rather than muscle Increases thermogenesis energy expenditure through heat production, primarily in brown and beige adipose tissue, not muscle tissue Increases hepatic fatty acid oxidation the liver burns more fat, reducing liver fat stores If these mechanisms shift the body's energy sourcing toward fat metabolism, the proportion of weight lost from lean tissue could theoretically be lower with retatrutide than with drugs that lack glucagon activity
This is an important effort
So you can take it as a pill, but we don't actually know what the absorption rate is
Understanding why you may still feel hungry on tirzepatidewhether due to dosage timing, individual response variability, lifestyle factors, or normal physiological hungercan help you optimize your treatment and set realistic expectations for appetite control throughout your weight management journey
Some protocols involve daily administration for a limited period, but this should only be done under the guidance of a licensed medical professional
The difference was meaningful in research terms but small in absolute terms, which is why responsible framing presents AOD 9604 as a possible adjunct to diet and training, not a replacement for them